Drug Catalog - Product Detail
METHAZOLAMIDE USP TB 50MG 100
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 00781-1071-01 | SANDOZ | 100 | 50MG | TABLET |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Methazolamide, a sulfonamide derivative, is a white crystalline powder, weakly acidic, and slightly soluble in water, alcohol and acetone. It is available as 25 mg and 50 mg tablets. The chemical name for methazolamide is N -[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3 H )-ylidene]-acetamide and it has the following structural formula: Methazolamide tablets, USP contain 25 mg or 50 mg of methazolamide. Inactive ingredients: croscarmellose sodium, hydroxypropyl methylcellulose, lactose (monohydrate), magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. chemicalstructure
How Supplied
HOW SUPPLIED Methazolamide tablets, USP for oral administration are available as: 25 mg: Round, white, unscored tablets debossed GG 78 on one side and plain on the reverse side, and supplied as: NDC 0781-1072-01 bottles of 100 NDC 0781-1072-10 bottles of 1000 50 mg: Round, white, scored tablets debossed GG 181 on one side and plain on the reverse side, and supplied as: NDC 0781-1071-01 bottles of 100 NDC 0781-1071-10 bottles of 1000 Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature). Dispense in a tight, light-resistant container.
Indications & Usage
INDICATIONS AND USAGE Methazolamide is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.
Dosage and Administration
DOSAGE AND ADMINISTRATION The effective therapeutic dose administered varies from 50 mg to 100 mg 2 or 3 times daily. The drug may be used concomitantly with miotic and osmotic agents.